School of Medicine
Showing 61-70 of 5,052 Results
-
Aijaz Ahmed, MD
Professor of Medicine (Gastroenterology and Hepatology)
BioDr. Ahmed is an internationally recognized hepatologist with expertise in the treatment of acute and chronic liver diseases. He is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. Currently, he serves as the Medical Director of the Adult Liver Transplant Program at Stanford University.
Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University. During his fellowship, he focused on clinical and research training in General and Transplant Hepatology.
For patients under his care, Dr. Ahmed remains dedicated to creating a personalized, comprehensive, and above-all a compassionate treatment plan. He outlines the diagnostic and follow-up management pathway in an individualized fashion; he updates his patients and their family/support at each step of the decision-making process; and he focuses on prioritizing the wishes of his patients and their family/support for an optimal outcome and quality of life.
Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada.
In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford ford University. He remains deeply interested in mentoring trainees and students al levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.
Dr. Ahmed’s research interests include 1) multidisciplinary approach to nonalcoholic fatty liver disease (NAFLD), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC), and 4) outcomes research in NAFLD, HCC, viral hepatitis, alcoholic liver disease, and liver transplantation. He heads a busy and productive outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.
He has published his findings in textbooks, abstracts, case reports, and high- profile medical journals including Gastroenterology, Journal of Hepatology, Hepatology American Journal of Gastroenterology, and other well-renowned peer-reviewed publications.
Dr. Ahmed and his team has made presentations to his peers at many national and international conferences: the American Association for the Study of Liver Disease, International Liver Congress, European Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, and more. His presentations have addressed leading-edge approaches to the treatment of chronic liver disease, liver cancer, and liver failure. He also has presented his insights into the gastrointestinal impact of COVID-19.
For his clinical, research, and teaching achievements, Dr. Ahmed has earned extensive recognition. His honors include being named as one of America’s Top Physicians by the Consumers’ Research Council of America.
He is an active member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases. -
Neera Ahuja
Professor of Medicine (Hospital Medicine)
Current Research and Scholarly InterestsClinical inpatient trials, Quality improvement, Assessing interventions with operations on throughput. SDOH/Health equity
Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system -
Raag Airan
Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Materials Science & Engineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.
-
Teddy J. Akiki, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Akiki's research focuses on advancing precision psychiatry through computational neuroscience approaches. His work centers on developing transformer-based foundation models for functional neuroimaging that can predict treatment responses and symptom trajectories in psychiatric disorders. Using multimodal connectomics (combining structural, functional, and diffusion MRI), he maps neural circuits underlying stress-related conditions, with particular emphasis on identifying dysconnectivity patterns in PTSD and depression. Dr. Akiki develops novel analytical methods for neuroimaging data, including network-restricted metrics and community detection frameworks optimized for functional time series. His translational work includes neuroimaging-augmented clinical trials of novel therapeutics for treatment-resistant psychiatric disorders, with the goal of implementing data-driven, personalized interventions based on individual neurobiological profiles.
-
Ahmad Al-Moujahed, MD, PhD, MPH
Assistant Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Ahmad Al-Moujahed is a board-certified, fellowship-trained ophthalmologist with Stanford Health Care. He is also an assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Al-Moujahed specializes in caring for retinal and macular diseases, as well as inherited retinal degenerations (IRDs), a group of genetic diseases that cause vision loss. He also specializes in vitreoretinal surgery to treat a range of diseases that affect vision. He is one of the only ophthalmologists in the nation with dedicated vitreoretinal surgery and IRD training and expertise. He is committed to providing compassionate care that improves eye health, vision, and quality of life.
As a physician-scientist, Dr. Al-Moujahed’s research focuses on investigating the origins of IRDs and developing novel treatments for these conditions. He is also involved in clinical trials exploring innovative experimental treatments for IRDs.
He is also deeply interested in the intersection of ophthalmology, public health, and global health. He has contributed to the development of educational programs for medical students and vision care initiatives in Syria and Lebanon, with the goal of expanding access to eye care in underserved communities.
Dr. Al-Moujahed has published his research in peer-reviewed journals, including Investigative Ophthalmology & Visual Science, Experimental Eye Research, Stem Cell Research, Scientific Reports, and American Journal of Ophthalmology. He has also published in Ophthalmology Retina; British Journal of Ophthalmology; European Journal of Ophthalmology; Ophthalmic Surgery, Lasers and Imaging Retina; and the International Journal of Retina and Vitreous.
He has also presented at several national conferences, including meetings of the Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, American Academy of Ophthalmology, and Retina Society.
Dr. Al-Moujahed is a member of the American Society of Retina Specialists, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology. He is also a member of the Syrian American Medical Society and serves on its Education and Ophthalmology Committee. -
Todd Alamin, MD, FAAOS
Professor of Orthopaedic Surgery
BioDr. Alamin is a board-certified, fellowship-trained orthopaedic surgeon and spine surgeon at Stanford Health Care Orthopaedics and Sports Medicine. He is director of the Spine Surgery Fellowship Program and the Minimally Invasive Spine Center and a professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine. Dr. Alamin completed his spine care and surgery fellowship training at Stanford University School of Medicine/St. Mary’s Medical Center.
Dr. Alamin specializes in advanced, minimally invasive treatments for a range of conditions affecting the spine. He is skilled at relieving pain that results from spinal stenosis, scoliosis, degenerative disc disease, arthritis, and traumatic injuries. He combines extensive expertise with decades of experience to deliver innovative, personalized care to each of his patients.
Dr. Alamin’s research interests include effective treatments for vertebral fractures, spinal deformities, scoliosis, herniated discs, and spondylolisthesis (when a vertebra slides out of place). As principal investigator for multiple clinical trials and research studies, Dr. Alamin has explored nerve ablation as a treatment for chronic low back pain and motion-preserving lumbar fusion techniques. He uses state-of-the-art medical devices, implants, and technology to make spine surgery more effective and help his patients move without pain.
Dr. Alamin is known around the world for the treatment of spine disorders and injuries. He has published more than 65 articles in numerous peer-reviewed journals, including Spine, The Spine Journal, Clinical Spine Surgery, International Journal of Spine Surgery, and Journal of Orthopaedic Research. He has also written several book chapters that focus on diagnosing and treating spine conditions.
A recognized leader in innovative spine surgery techniques, Dr. Alamin has invented dozens of medical devices, methods, and techniques for spine surgery. He holds a number of patents for his inventions, many of which have revolutionized back pain treatments. Physicians around the globe use his techniques and devices to help their patients with spine conditions.
Dr. Alamin has been invited to present at conferences around the globe about spinal fusion procedures, novel techniques to treat spinal stenosis, and the latest medical devices to treat degenerative spondylolisthesis. He has lectured at annual meetings for the Association of Bone and Joint Surgeons, the North American Spine Society, and the International Society for the Study of the Lumbar Spine.
Dr. Alamin is a fellow of the American Academy of Orthopaedic Surgeons. He is a member of the North American Spine Society, the International Society for the Study of the Lumbar Spine, the Spine Arthroplasty Society, and the Society for Minimally Invasive Spine Surgery.
